SABS
SAB Biotherapeutics Inc
3.20$
+0.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.79 | 20.45 | 22.27 | 5.49 | 0.41 | 0.14 | 0.00 | |
| – | – | 0.60 | 0.76 | 0.68 | 0.52 | 0.05 | |
| 0.79 | 20.45 | 21.66 | 4.74 | -0.27 | -0.37 | -0.05 | |
| 1.84 | 10.33 | 20.92 | 8.37 | 2.99 | 3.26 | 0.56 | |
| 0.94 | 2.51 | 6.25 | 3.76 | 4.31 | 1.51 | 0.24 | |
| 2.79 | 12.84 | 26.56 | 11.38 | 6.62 | 4.26 | 0.75 | |
| -2.00 | 7.61 | -4.90 | -6.64 | -6.90 | -4.63 | -0.80 | |
| 0.10 | 0.17 | 0.11 | 0.07 | 0.06 | 0.03 | 0.00 | |
| -2.07 | 7.45 | -6.27 | -4.30 | -7.64 | -3.68 | 0.22 | |
| 0.10 | 0.18 | 0.11 | 0.01 | 0.00 | – | – | |
| -2.07 | 7.45 | -6.27 | -4.31 | -7.64 | -3.68 | 0.22 | |
| -1.89 | 7.82 | -5.56 | -3.47 | -6.91 | -3.13 | 0.27 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.